Note 8 - Segment Information and Dissaggregated Revenue

6 Months Ended

Dec. 31, 2018

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

8.

Segment Information

and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

December 31, 2018

and

2017

were

$1,274

and

$1,248,

respectively, and for the

six

months ended

December 31, 2018

and

2017

were

$2,513

and

$2,906,

respectively.

Financial information relating to the

three

months ended

December 31, 2018

and

2017

operations by business segment and disaggregated revenues are as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit		Depreciation			Expenditures
Contract Manufacturing	2018	$	10,498	$	1,258	$	11,756	$	1,246	$	66	$	269
	2017		9,159		1,199		10,358		896		55		109
Branded Proprietary Products	2018		48		12		60		21		-		-
	2017		162		10		172		65		1		-
Other Nutraceutical Businesses	2018		181		4		185		63		-		-
	2017		231		39		270		87		1		-
Total Company	2018		10,727		1,274		12,001		1,330		66		269
	2017		9,552		1,248		10,800		1,048		57		109

Financial information relating to the

six

months ended

December 31, 2018

and

2017

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital
		Customers		Customers		Total		Profit		Depreciation			Expenditures
Contract Manufacturing	2018	$	19,153	$	2,455	$	21,608	$	2,328	$	131	$	$287
	2017		16,981		2,782		19,763		1,731		129		202
Branded Proprietary Products	2018		119		19		138		42		-		-
	2017		181		21		202		97		2		13
Other Nutraceutical Businesses	2018		520		39		559		179		1		-
	2017		502		103		605		225		1		1
Total Company	2018		19,792		2,513		22,305		2,549		132		287
	2017		17,664		2,906		20,570		2,053		132		216

	Total Assets as of
	December 31,		June 30,
	2018		2018
Contract Manufacturing	$	20,141	$	12,200
Branded Proprietary Products		545		543
Other Nutraceutical Businesses		1,889		1,825
Total Company	$	22,575	$	14,568